Synapse - Adam Schoenfeld

Results (136)

Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)

Meeting Abstract

Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer

Meeting Abstract

Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer

Journal Article

Ricciuti, B.; Elkrief, A.; Alessi, J.; Wang, X.; Li, Y.; Gupta, H.; Muldoon, D. M.; Bertram, A. A.; Pecci, F.; Lamberti, G.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

Journal Article

Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
Journal for ImmunoTherapy of Cancer (2023)

Fulltext@MSK | Save

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC

Journal Article

Alessi, J. V.; Ricciuti, B.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; Elkrief, A.; Rodig, S. J.; Lebow, E. S.; Eicholz, J. E.; more...
Nature Communications (2023)

Fulltext@MSK | Save

Efficacy of first-line (1L) nivolumab (N) plus ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)

Meeting Abstract

Borghaei, H.; Balli, D.; Paz-Ares, L.; Reck, M.; Ramalingam, S. S.; Brahmer, J. R.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Gainor, J.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC

Journal Article

Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Wang, X.; Cortellini, A.; Vaz, V. R.; Lamberti, G.; Frias, R. L.; Venkatraman, D.; Fulgenzi, C. A. M.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Letter to the editor: Reply to Zhao, Wu, and Ma

Correspondence

Alessi, J. V.; Elkrief, A.; Ricciuti, B.; Schoenfeld, A. J.; Awad, M. M.
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Efficacy of first-line (1L) nivolumab (N) + ipilimumab (I) by tumor histologic subtype in patients (pts) with metastatic nonsquamous NSCLC (mNSQ-NSCLC)